Faron Pharma secures UK innovation passport for blood cancer immunotherapy
The MHRA has also granted approval to Faron Pharmaceuticals to conduct the BEXMAB trial of Clevegen in the UK.
The MHRA has also granted approval to Faron Pharmaceuticals to conduct the BEXMAB trial of Clevegen in the UK.
What's Your Reaction?
